首页> 美国卫生研究院文献>Springer Open Choice >Four types of cannabimimetic indazole and indole derivatives ADB-BINACA AB-FUBICA ADB-FUBICA and AB-BICA identified as new psychoactive substances
【2h】

Four types of cannabimimetic indazole and indole derivatives ADB-BINACA AB-FUBICA ADB-FUBICA and AB-BICA identified as new psychoactive substances

机译:被确定为新型精神活性物质的四种大麻素吲唑和吲哚衍生物ADB-BINACAAB-FUBICAADB-FUBICA和AB-BICA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We identified four cannabimimetic indazole and indole derivatives in new illegal psychoactive substances seized from a clandestine laboratory in China. These four derivatives included N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indazole-3-carboxamide (ADB-BINACA, >1), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide (AB-FUBICA, >2), N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide (ADB-FUBICA, >3), and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide (AB-BICA, >4). These compounds were identified by liquid chromatography–high-resolution mass spectrometry, gas chromatography–mass spectrometry, and nuclear magnetic resonance spectroscopy. No chemical or pharmacological data about compound >4 has appeared until now, making this the first report on this compound. Compounds >1, >2, and >3 have previously been reported to have a high affinity for cannabinoid CB1 and CB2 receptors, but this is the first report of their presence in illegal products.Electronic supplementary materialThe online version of this article (doi:10.1007/s11419-015-0297-2) contains supplementary material, which is available to authorized users.
机译:我们从中国一个秘密实验室缉获的新非法精神活性物质中鉴定出四种大麻素吲哚和吲哚衍生物。这四个衍生物包括N-(1-氨基-3,3-二甲基-1-氧丁烷-2-基)-1-苄基-1H-吲唑-3-羧酰胺(ADB-BINACA,> 1 ),N-(1-氨基-3-甲基-1-氧丁烷-2-基)-1-(4-氟苄基)-1H-吲哚-3-羧酰胺(AB-FUBICA,> 2 ),N-(1-氨基-3,3-二甲基-1-氧杂丁-2-基)-1-(4-氟苄基)-1H-吲哚-3-羧酰胺(ADB-FUBICA,> 3 )和N-(1-氨基-3-甲基-1-氧丁烷-2-基)-1-苄基-1H-吲哚-3-羧酰胺(AB-BICA,> 4 ) 。这些化合物通过液相色谱-高分辨率质谱,气相色谱-质谱和核磁共振波谱鉴定。到目前为止,尚未出现有关化合物> 4 的化学或药理数据,这是该化合物的第一份报告。先前已经报道化合物> 1 ,> 2 和> 3 与大麻素CB1和CB2受体具有高亲和力,但这是首次报道电子补充材料本文的在线版本(doi:10.1007 / s11419-015-0297-2)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号